This study analyzes and reports Clostridium difficile infection (CDI) rates, risk factors, and associations with postoperative outcomes in the Veterans Health Administration (VHA).
Several CDI risk factors have been identified, including advanced age, severe comorbidity, hospitalization, and antibiotic exposure. 10, 11 Several studies have examined the risk factors for colorectal cancer surgery and cardiac surgery. [12] [13] [14] To our knowledge, no study has reported risk factors associated with CDI across a variety of surgical specialties in the Veterans Health Administration (VHA), a predominantly male and elderly surgical population.
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The 134 VHA Surgery Programs perform approximately 400 000 surgical procedures annually. In 2007, the Veterans Affairs (VA) Surgical Quality Improvement Program (VASQIP) started collecting 30-day postoperative CDI data in eligible noncardiac surgical procedures. The objectives of this study were to document the CDI incidence in the VHA over a 4-year period across different surgical procedures, identify the risk factors associated with CDI, and determine the impact of CDI on postoperative mortality, morbidity, and hospital length of stay.
Methods
The VASQIP prospectively collects preoperative demographics, comorbidities, operative characteristics, and 30-day postoperative outcomes for eligible cases in VA facilities with an approved VHA Surgery Program. [16] [17] [18] By policy, the VHA National Surgery Office analyzes VASQIP data on a quarterly basis, publishes quarterly and annual reports, and monitors quality improvement. 19 This operational retrospective cohort study analyzed all noncardiac VASQIP-assessed cases from 134 VHA surgical programs from October 1, 2009 , to September 30, 2013. For patients with multiple operations within 30 days, only the first case (index procedure) was included in the analysis. Postoperative CDI incidences within 30 days were captured at the VA facility and recorded by a VHA surgical quality nurse. Clostridium difficile infection cases were included regardless of whether diagnosis occurred during index hospitalization, readmission, or outpatient treatment. Clostridium difficile infection was defined with 2 components: a positive culture re- significantly older than patients without CDI (mean age, 67.4 vs 60.6; P < .001). Several preoperative comorbidities were more common in patients with CDI than those without CDI, including congestive heart failure, history of chronic obstructive pulmonary disease, ascites, acute renal failure, impaired sensorium, hemiplegia, rest pain/gangrene, bleeding disorder, wound infection, and weight loss greater than 10% within 6 months before surgery. Patients with impaired functional status were more prevalent in the CDI group than in the non-CDI group. A higher American Society of Anesthesiology (ASA) classification was significantly associated with CDI, with a moribund patient having significantly higher risk of CDI compared with a healthy patient (1.7% vs 0.03%; P < .001; Table 1 ).
A total of 1833 30-day postoperative CDIs were diagnosed. Of these, 1239 cases (67.6%) were diagnosed as having a CDI during index hospitalization, and others were diagnosed as having a CDI on readmission or as outpatients. Table 2 shows the distribution of case volumes and VASQIP 30-day postoperative CDI rates across the surgical specialties. There were 12 noncardiac main surgical specialties represented in the cohort. In this VASQIP surgery population, general surgery and orthopedic surgery were the specialties with the most prevalent case volumes (32.1% and 28.4%, respectively), and transplant and oral surgery were the specialties with the lowest case volumes (0.2% and 0.4%, respectively). The overall 30-day postoperative CDI rate was 0.4% in this cohort. The CDI rate was significantly different among the surgery specialties. Transplant surgery had the highest CDI rate with 2.37%, and there was no CDI incidence among oral surgery procedures during the 4-year period. The median time to postoperative CDI was 9 days, but it was noted to vary among surgery specialties. The CDI rate also varied among the 134 VHA Surgery Table 2 ). The mean CDI rate of inpatient complex surgical programs was 0.44%, with a range from 0.0% to 1.4%. The mean CDI rates of ambulatory surgery centers and inpatient standard surgical programs were lower compared with those of the inpatient intermediate and inpatient complex surgical programs ( Table 2 ). The CDI rates for complex inpatient, inpatient intermediate, inpatient standard, and ambulatory surgery center surgical programs were 0.44%, 0.31%, 0.06%, and 0.04%, respectively (P < .001) ( Table 2 ). The data did not show a significant temporal trend at the national level. The CDI rates were 0.4%, 0.4%, 0.4%, and 0.4%, respectively, from fiscal year 2010 to 2013 (Figure) . The VHA policy assigns a surgical procedure complexity designation to each surgical procedure identified by the CPT code. 17, 18 In the 4-year period, most of the VASQIP-eligible noncardiac surgical procedures were defined as standard (57.1%) or intermediate (39.4%) based on the CPT code, while 2.4% were complex surgical procedures (Table 2) . Surgical complexity designation of the surgical procedure was significantly associated with CDI. The CDI rates for complex, intermediate, and standard surgical procedures were 1.16%, 0.59%, and 0.23%, respectively (P < .001). The CDI rate was significantly higher in emergency procedures (1.43%) compared with nonemergency procedures (0.34%; P < .001) ( Table 2 ). There were significant differences in intraoperative work relative value unit assignments and wound classification between CDI cases and non-CDI cases ( Table 1 ). The mean (SD) intraoperative work relative value unit was 20.6 (10.7) for those with postoperative CDI and 14.5 (8.5) for those without postoperative CDI (P < .001). Intraoperative wound classification was significantly associated with increased risk of CDI. The CDI rates for clean, clean/contaminated, contaminated, and infected wound classifications were 0.2%, 0.59%, 1.28%, and 1.4%, respectively (P < .001) ( Table 2) .
Postoperative 30-day mortality was significantly higher for patients with postoperative CDI than those without CDI (5.29% vs 1.02%; P < .001) ( Table 1) . Thirty-day postoperative morbidity events, including cardiac complications, central nervous system events, pulmonary complications, renal impairment, and surgical site infection, occurred more frequently in the CDI group than in the non-CDI group. In the CDI group, 20.95% had 30-day pulmonary complications vs only 2.45% in the non-CDI group (P < .001). The renal impairment complication rate was higher in the CDI group than the non-CDI group (16.2% vs 2.0%; P < .001; Table 1 ). The mean postoperative hospital length of stay was significantly longer for patients with CDI than those without CDI (17.9 days vs 3.6 days; P < .001). The number of different antibiotic classes administered within 60 days before surgery was significantly associated with CDI. The CDI rate for only 1 antibiotic class administration was 0.3%, while it was 1.5% for cases with 3 or more antibiotics used preoperatively (Table 1) .
Sensitivity analysis using the matched cases validated the association of postoperative CDI with postoperative mortality, morbidity, and hospital stay ( Table 3) . Patients with CDI were associated with 3.9 increased odds of 90-day mortality (95% CI, 2.9-5.4; P < .001). Patients with CDI were 3.0 times more likely to die within 180 days compared with patients ated with increased risk for CDI. The following preoperative comorbidities and intraoperative characteristics were also independent risk factors of CDI: a higher ASA classification, bleeding disorder, complexity of surgical procedure, higher intraoperative work relative value unit, emergent case status, nonindependent functional status, hemiplegia, history of chronic obstructive pulmonary disease, rest pain/ gangrene, wound classification, weight loss within 6 months greater than 10.0%, hospital complexity, number of antibiotic classes prescribed before surgery, and length of preoperative hospital stay.
Discussion
The overall postoperative incidence of CDI of 0.4% for this VHA study population is low compared with previously published rates of postoperative CDI. [5] [6] [7] To our knowledge, this is the first study to report that the rate of postoperative CDI is significantly associated with the number of antibiotic classes administrated within 60 days before surgery. To our knowledge, this is also the first study to report that the rate of postoperative CDI is significantly associated with the complexity of the surgical procedure and the complexity of the surgical program in which the procedure is performed. The diversity of the surgical population and surgical procedures may contribute to differences in reported CDI incidence. Selection bias may also play a role in the variability of reported CDI rates because most published studies of CDI are nonrandomized trials. To minimize the selection bias, this study included all the VASQIPassessed surgical cases performed by the VHA for a 4-year period for 12 specialties. The study team did not find a temporal trend for CDI rates in the VHA surgical patient population for the 4-year period studied. This finding appears contradictory to reported rising CDI rates among hospitalized patients in the United States. 21, 22 Some surgical procedures have been reported as a risk factor for CDI. 23, 24 In this study, transplant patients had the highest 30-day postoperative CDI rate (2.37%) while gynecology and oral surgery had the lowest CDI rates (0.06% and 0.00%, respectively). The incidence of CDI for solid organ transplant from one institutional study was 12.4%. 25 In this study, the CDI rate was 2.6% and 3.1%
for kidney and lung transplant cases, respectively. Our findings indicate that patient demographics and preoperative clinical characteristics vary significantly among surgical procedures. These differences likely contribute to the CDI rate variability across surgical specialties. Independent risk factors for CDI were found to be advanced age, albumin less than 3.5 g/dL, higher ASA classification, bleeding disorder, dialysis, impaired functional status, hematocrit less than 38%, hemiplegia, history of chronic obstructive pulmonary disease, rest pain/gangrene, open wound infection, weight loss greater than 10% within 6 months before surgery, duration of hospitalization before surgery, and preoperative cumulative antibiotic use. Moreover, the number of antibiotic classes administrated within 60 days before surgery was significantly associated with an increased risk of CDI. The CDI rate of cases with 3 or more different antibiotic classes prescribed was almost 6 times higher than that for cases with no or only 1 antibiotic class prescribed within 60 days before surgery.
The mean length of postoperative hospital stay for functionally independent patients was 3 days compared with 19 days for totally functional dependent patients, and the mean length of postoperative hospital stay for ASA classification I patients was 0.6 days compared with 19 days for ASA classification V patients. Preoperative hospital stay can plexity, emergent case status, and complexity of the surgical program) were identified as statistically significant risk factors for CDI after surgery. These factors reflect the illness of patients, duration of operation, and hospital setting; each is an established risk factor for CDI.
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The CDI rate significantly varied among the 134 VHA Surgery Programs (0% to 1.35%). Programs with high CDI rates remained high, and programs with low CDI rates remained low in the study. Based on this study, this VA facility variance is likely owing to the case mix of patients and the complexity of the surgical procedures performed. However, medical practice may also play a significant role in CDI. In this report, surgical procedures and patients at risk for CDI have been identified. Surgical administrators and clinical teams may consider the results of this study to target interventions for specific patients undergoing high-risk procedures. Such interventions include selective antibiotic administration, early testing of at-risk 
